KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Gsk (GSK) Income from Non-Controlling Interests (2016 - 2026)

Gsk has reported Income from Non-Controlling Interests over the past 18 years, most recently at $137.5 million for Q1 2026.

  • For Q1 2026, Income from Non-Controlling Interests fell 26.23% year-over-year to $137.5 million; the TTM value through Mar 2026 reached $706.1 million, down 2.55%, while the annual FY2025 figure was $762.2 million, 57.93% up from the prior year.
  • Income from Non-Controlling Interests for Q1 2026 was $137.5 million at Gsk, up from $121.0 million in the prior quarter.
  • Over five years, Income from Non-Controlling Interests peaked at $588.8 million in Q4 2022 and troughed at $44.4 million in Q1 2024.
  • A 5-year average of $206.3 million and a median of $171.4 million in 2023 define the central range for Income from Non-Controlling Interests.
  • Biggest five-year swings in Income from Non-Controlling Interests: tumbled 83.76% in 2022 and later skyrocketed 319.85% in 2025.
  • Year by year, Income from Non-Controlling Interests stood at $588.8 million in 2022, then crashed by 44.77% to $325.2 million in 2023, then tumbled by 34.48% to $213.1 million in 2024, then tumbled by 43.19% to $121.0 million in 2025, then increased by 13.61% to $137.5 million in 2026.
  • Business Quant data shows Income from Non-Controlling Interests for GSK at $137.5 million in Q1 2026, $121.0 million in Q4 2025, and $176.8 million in Q3 2025.